von Willebrand Disease, Type 3
|
0.800 |
GeneticVariation
|
disease |
BEFREE |
We report the case of a 6-year-old girl with type 3 von Willebrand disease in whom inhibitors were sought due to ineffective haemostasis together with lower than expected von Willebrand factor (VWF) recoveries after a surgical procedure.
|
31714257 |
2020 |
von Willebrand Disease, Type 3
|
0.800 |
GeneticVariation
|
disease |
BEFREE |
In type 3 von Willebrand disease (VWD3), the most severe form with absent von Willebrand factor (VWF), the bleeding phenotype is variable.
|
30836803 |
2020 |
von Willebrand Disease, Type 3
|
0.800 |
Biomarker
|
disease |
BEFREE |
Addition of von Willebrand factor to the ristocetin assay of a VWD type 3 patient restored the reaction of the whole blood probe to match the response of a healthy person.
|
30630422 |
2019 |
von Willebrand Disease, Type 3
|
0.800 |
Biomarker
|
disease |
BEFREE |
The diagnosis of VWD type 3 was confirmed by VWF antigens less than 5 IU/dL.
|
31532876 |
2019 |
von Willebrand Disease, Type 3
|
0.800 |
Biomarker
|
disease |
BEFREE |
Objectives To develop an integrative Sleeping Beauty (SB) transposon-mediated VWF gene transfer approach in a preclinical mouse model of severe VWD.
|
29288565 |
2018 |
von Willebrand Disease, Type 3
|
0.800 |
Biomarker
|
disease |
BEFREE |
This evidence is supported by studies on blood outgrowth EC (BOEC) from patients with lack of VWF synthesis (type 3 von Willebrand disease [VWD]).
|
29866817 |
2018 |
von Willebrand Disease, Type 3
|
0.800 |
GeneticVariation
|
disease |
BEFREE |
The natural course of the bleeding symptoms of the patient with type-3 vWD was attenuated, with no detectable hemostatic levels of von Willebrand factor antigen (vWF:Ag) after transplantation.
|
29931985 |
2018 |
von Willebrand Disease, Type 3
|
0.800 |
AlteredExpression
|
disease |
BEFREE |
VEGF levels were negatively associated with VWF levels as type 3 VWD patients had the highest VEGF levels.
|
29304535 |
2018 |
von Willebrand Disease, Type 3
|
0.800 |
AlteredExpression
|
disease |
BEFREE |
Diagnosis of type 3 VWD was based on undetectable VWF antigen levels in the plasma.
|
29984440 |
2018 |
von Willebrand Disease, Type 3
|
0.800 |
Biomarker
|
disease |
BEFREE |
The development of inhibitory alloantibodies against VWF is a rare but often severe complication encountered during the treatment of type 3 VWD, which is associated with a lack of hemostatic response to infused VWF concentrates and more rarely with allergic, even anaphylactic, reactions.
|
29165738 |
2018 |
von Willebrand Disease, Type 3
|
0.800 |
AlteredExpression
|
disease |
BEFREE |
Moreover, increased clearance also contributes to reduced VWF levels in many patients with type 2 and type 3 VWD.
|
30378120 |
2018 |
von Willebrand Disease, Type 3
|
0.800 |
Biomarker
|
disease |
BEFREE |
We report a case of severe autoimmune AVWS in a woman with SLE who presented with clinical and laboratory features of type 3 VWD (undetectable VWF antigen, ristocetin cofactor activity, and VWF multimers).
|
28512017 |
2017 |
von Willebrand Disease, Type 3
|
0.800 |
Biomarker
|
disease |
GENOMICS_ENGLAND |
Molecular and clinical profile of von Willebrand disease in Spain (PCM-EVW-ES): comprehensive genetic analysis by next-generation sequencing of 480 patients.
|
28971901 |
2017 |
von Willebrand Disease, Type 3
|
0.800 |
AlteredExpression
|
disease |
BEFREE |
In conclusion, VWFpp identified severe type 1 VWD with very low VWF levels in patients who had previously been classified as type 3 VWD.
|
25673639 |
2015 |
von Willebrand Disease, Type 3
|
0.800 |
GeneticVariation
|
disease |
BEFREE |
Four cases had VWF:Ag < 3 IU dL(-1) and VWF mutations consistent with Type 3 VWD.
|
25780857 |
2015 |
von Willebrand Disease, Type 3
|
0.800 |
AlteredExpression
|
disease |
BEFREE |
Bleeding symptoms in general are more severe with decreasing VWF levels and more severe in type 2 and type 3 VWD compared with type 1 VWD.
|
25696906 |
2014 |
von Willebrand Disease, Type 3
|
0.800 |
GeneticVariation
|
disease |
BEFREE |
The development of alloantibodies against von Willebrand factor (VWF) represents a rare but serious complication of treatment of von Willebrand disease (VWD), occurring in ~5% to 10% of type 3 VWD patients.
|
23297130 |
2013 |
von Willebrand Disease, Type 3
|
0.800 |
GeneticVariation
|
disease |
BEFREE |
The molecular pathology of type 3 VWD has been similarly well characterized, with an array of different mutation types producing either a null phenotype or the production of VWF that is not secreted.
|
24065240 |
2013 |
von Willebrand Disease, Type 3
|
0.800 |
Biomarker
|
disease |
BEFREE |
Severe type 3 VWD (VWD3) is characterised by complete absence or presence of trace amounts of non-functional von Willebrand factor (VWF).
|
23407766 |
2013 |
von Willebrand Disease, Type 3
|
0.800 |
GeneticVariation
|
disease |
BEFREE |
The molecular pathology of type 3 VWD has been similarly well characterized, with an array of different mutation types producing either a null phenotype or the production of VWF that is not secreted.
|
24319188 |
2013 |
von Willebrand Disease, Type 3
|
0.800 |
GeneticVariation
|
disease |
BEFREE |
In five IC (15%), two mutant VWF alleles were not identified to explain the type 3 VWD phenotype.
|
23311757 |
2013 |
von Willebrand Disease, Type 3
|
0.800 |
GeneticVariation
|
disease |
BEFREE |
VWD is classified into quantitative deficiencies of VWF (type 1 and type 3 VWD) and qualitative variants (type 2 VWD), because of a dysfunctional VWF.
|
23852183 |
2013 |
von Willebrand Disease, Type 3
|
0.800 |
Biomarker
|
disease |
BEFREE |
Shear-induced GPVI shedding also occurred in platelet-rich plasma or washed platelets isolated from a von Willebrand disease type 3 patient with no detectable VWF, implying that shear-induced activation of platelet metalloproteinases can occur in the absence of GPVI and GPIbα ligands.
|
22431567 |
2012 |
von Willebrand Disease, Type 3
|
0.800 |
GeneticVariation
|
disease |
BEFREE |
This study extends our previous finding that most of the mutations that we identified in VWD3 patients arise independently and are scattered throughout the entire VWF gene.
|
22674667 |
2012 |
von Willebrand Disease, Type 3
|
0.800 |
Biomarker
|
disease |
BEFREE |
Although the incidence of VWD3 is rare, the condition is of considerable interest because of its severe clinical presentation, the need for replacement therapy and the risk of alloantibodies following infusion of plasma-derived VWF concentrates.
|
22722677 |
2012 |